Anti-doping authorities rejected claims that French rider Paul Seixas received favorable treatment at the Tour de France. The cutoff-safe record says Seixas had not undergone the exceptional nighttime testing imposed on rivals, while the International Testing Agency denied that France's anti-doping agency selected riders. [1]
The dispute follows the paper's July 20 account of a Paris judge authorizing overnight tests for Jonas Vingegaard and Tadej Pogacar. Judicial authorization closed one authority gate but left selection grounds, sample results, welfare review and remedy open. Wednesday's institutional denial does not close them.
Unequal observed timing is not yet unequal treatment. Riders can be selected under different intelligence, performance, biological and scheduling conditions. Proving favoritism requires the selector, rules, comparable population and reasons. Proving neutrality requires more than an agency saying it acts independently.
The International Testing Agency said it controls Tour strategy and decides who is tested and when, with the French agency providing personnel when needed. [1] That allocation of responsibility is useful. It identifies the institution that should preserve selection and timing records rather than allowing a national favoritism claim to float without an accountable decision-maker.
The source page was modified after the edition cutoff. The assignment therefore excludes named-rider quotations, detailed testing hours, risk-factor lists and later institutional endorsements visible in the current body. The admitted record is the public rejection, unequal observed nighttime-testing status and denial of French selection.
A fair comparison needs a denominator. How many riders were tested overnight, at what hours, from which teams and positions, under what categories? How often were similar risk indicators associated with ordinary-hour tests? Without that table, one conspicuous French rider and several rivals make a narrative, not an audit.
Confidential anti-doping intelligence need not be published live. It can be reviewed by an independent body after samples and competition are protected. Aggregate reporting can show whether nationality, team or ranking correlates with exceptional timing. Athletes can receive a complaint route that tests welfare and equal treatment without disclosing sensitive allegations publicly.
No verified X status emerged from the exact Paul Seixas nighttime-testing search. Platform accusations and defenses therefore remain unobserved. The Guardian's headline stages rivalry and rebuttal; the consequence is that both sides can claim a verdict while the selection rule stays opaque. [1]
Sample results are another separate record. Exceptional timing does not imply a positive test. Absence of a public violation does not provide a published negative result. Chain of custody and laboratory processing must remain detached from the debate over who was selected and when.
Equal treatment need not mean identical schedules for every rider. It means differences arise from a defensible rule applied consistently, with exceptional intrusion proportionate to a documented need. That standard can protect anti-doping intelligence and athlete rest at once. A confidential reviewer could test the reasons while public aggregate data reveal whether exceptional hours cluster around nationality, team or race position without naming uncharged athletes. Fairness requires both halves.
The authorities have now named who controls selection and rejected French favoritism. [1] That advances governance by one step. The next step is an auditable method, comparable timing data, confidential grounds review and a welfare remedy. Suspicion alone is not proof of bias, but denial is not proof of equal treatment.
-- AMARA OKONKWO, Lagos